Murine oncogenicity and pharmacokinetics studies of 9-cis-UAB30, an RXR agonist, for breast cancer chemoprevention.

about

The retinoid X receptors and their ligands Advances in drug design with RXR modulators The CDK4/6 inhibitor PD0332991 reverses epithelial dysplasia associated with abnormal activation of the cyclin-CDK-Rb pathway Retinoids and rexinoids in cancer prevention: from laboratory to clinic.

P2860

Q24562747-72DC12D6-598E-4A57-B566-FF92E181B049 Q28274388-076F6EF0-A952-448A-8A74-C1A08FADBA97 Q36010739-2989B00C-EECA-4BEC-A691-08639D6788CB Q36680198-4449A23A-5F19-42BA-83C2-73C835E32C1E

P2860

Murine oncogenicity and pharmacokinetics studies of 9-cis-UAB30, an RXR agonist, for breast cancer chemoprevention.

Item

http://www.wikidata.org/entity/Q43119645

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Murine oncogenicity and pharma ...... breast cancer chemoprevention.

@en

Murine oncogenicity and pharma ...... breast cancer chemoprevention.

@nl

type

Item

label

Murine oncogenicity and pharma ...... breast cancer chemoprevention.

@en

Murine oncogenicity and pharma ...... breast cancer chemoprevention.

@nl

prefLabel

Murine oncogenicity and pharma ...... breast cancer chemoprevention.

@en

Murine oncogenicity and pharma ...... breast cancer chemoprevention.

@nl

P1476

Murine oncogenicity and pharma ...... breast cancer chemoprevention.

@en

P2093

Carol J Detrisac

http://www.w3.org/2001/XMLSchema#string

David L McCormick

http://www.w3.org/2001/XMLSchema#string

Izet M Kapetanovic

http://www.w3.org/2001/XMLSchema#string

Michael J Cwik

http://www.w3.org/2001/XMLSchema#string

Thomas L Horn

http://www.w3.org/2001/XMLSchema#string

William D Johnson

http://www.w3.org/2001/XMLSchema#string

P2860

Multicenter phase II study of oral bexarotene for patients with metastatic breast cancer

The utility of genetically modified mouse assays for identifying human carcinogens: a basic understanding and path forward. The Alternatives to Carcinogenicity Testing Committee ILSI HESI

P53+/- hemizygous knockout mouse: overview of available data.

Role of retinoid receptors in the prevention and treatment of breast cancer.

Retinoids in chemoprevention and differentiation therapy.

Selective retinoids and rexinoids in cancer therapy and chemoprevention.

Bexarotene: a clinical review.

Use of transgenic mice in carcinogenicity hazard assessment.

Clinical trials with retinoids for breast cancer chemoprevention.

Induction of hepatic cytochrome P450 enzymes: methods, mechanisms, recommendations, and in vitro-in vivo correlations.

P304

157-164

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1091581809360070

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20335511

http://www.w3.org/2001/XMLSchema#string

Murine oncogenicity and pharmacokinetics studies of 9-cis-UAB30, an RXR agonist, for breast cancer chemoprevention.

about

P2860

P2860

Murine oncogenicity and pharmacokinetics studies of 9-cis-UAB30, an RXR agonist, for breast cancer chemoprevention.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698